- Home
- ENLV vs DXST Comparison
ENLV vs DXST Comparison
Compare ENLV & DXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- DXST
- Stock Information
- Founded
- ENLV 2005
- DXST 2011
- Country
- ENLV Israel
- DXST China
- Employees
- ENLV N/A
- DXST N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- DXST
- Sector
- ENLV Health Care
- DXST
- Exchange
- ENLV Nasdaq
- DXST NYSE
- Market Cap
- ENLV 20.7M
- DXST 20.3M
- IPO Year
- ENLV 1995
- DXST 2025
- Fundamental
- Price
- ENLV $1.01
- DXST $1.33
- Analyst Decision
- ENLV Strong Buy
- DXST
- Analyst Count
- ENLV 2
- DXST 0
- Target Price
- ENLV $10.00
- DXST N/A
- AVG Volume (30 Days)
- ENLV 146.1K
- DXST 54.3K
- Earning Date
- ENLV 04-11-2025
- DXST 01-01-0001
- Dividend Yield
- ENLV N/A
- DXST N/A
- EPS Growth
- ENLV N/A
- DXST 13.11
- EPS
- ENLV N/A
- DXST 0.14
- Revenue
- ENLV N/A
- DXST $11,542,292.00
- Revenue This Year
- ENLV N/A
- DXST N/A
- Revenue Next Year
- ENLV N/A
- DXST N/A
- P/E Ratio
- ENLV N/A
- DXST $8.91
- Revenue Growth
- ENLV N/A
- DXST 22.18
- 52 Week Low
- ENLV $0.81
- DXST $0.86
- 52 Week High
- ENLV $4.59
- DXST $5.74
- Technical
- Relative Strength Index (RSI)
- ENLV 44.89
- DXST N/A
- Support Level
- ENLV $0.92
- DXST N/A
- Resistance Level
- ENLV $1.13
- DXST N/A
- Average True Range (ATR)
- ENLV 0.10
- DXST 0.00
- MACD
- ENLV -0.01
- DXST 0.00
- Stochastic Oscillator
- ENLV 24.32
- DXST 0.00
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.